Karyopharm Therapeutics, Inc. (KPTI)
7.21
+0.89
(+14.08%)
USD |
NASDAQ |
Apr 07, 16:00
7.13
-0.08
(-1.11%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 150.89M for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 170.39B |
| Catalyst Pharmaceuticals, Inc. | 3.054B |
| Alnylam Pharmaceuticals, Inc. | 40.97B |
| Agios Pharmaceuticals, Inc. | 2.075B |
| Ocugen, Inc. | 564.09M |
Market Cap Related Metrics
| PS Ratio | 0.6147 |
| PEG Ratio | -0.0018 |
| Price | 7.21 |
| Earnings Yield | -202.1% |
| PEGY Ratio | -0.0018 |